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As the main complication of diabetes-related kidney damage, diabetic nephropathy (DN) is a complex clinical 
problem worldwide. As long non-coding RNAs (lncRNAs) play vital roles in DN, we would like to investigate the 
effect of lncRNA Rpph1 on glomerular mesangial inflammatory cytokines in diabetic nephropathy (DN). 
Compared with normal mice, Rpph1 was significantly up-regulated in kidney tissues of DN mice. Meanwhile, 
high-glucose cultured mesangial cells showed significantly up-regulation of Rpph1 expression in cultured 
mesangial cells. In addition, bioinformatics confirmed that Rpph1 does not have the ability to encode proteins. 
Moreover, the levels of TNF-α and MCP-1 were significantly up-regulated after overexpression of Rpph1 while 
down-regulation of Rpph1 results in the decreased expression of TNF-α and MCP-1. In conclusion, the lncRNA 
Rpph1 is highly expressed in mesangial cells of DN mice and the expression of inflammation-related factors is 
enhanced in high glucose environment which suggest that Rpph1 may be associated with the development of 
diabetic nephropathy. 
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Diabetes is a multi-pathogenic metabolic disease caused by 
absolute insulin deficiency or insulin utilization disorders, and 
persistent high blood sugar. Diabetes has multiple 
complications that cause long-term damage and dysfunction 
in a variety of organs, including the eyes, kidneys, and heart. 
Diabetic nephropathy (DN) is a serious complication of 
diabetes, in which renal fibrosis and activation of 
myofibroblasts are the main causes of end-stage severe renal 
damage [1]. Persistent hyperglycemia is considered to be the 
driving force for the development of DN, but in fact, the 
pathogenesis of DN is numerous, involving various 
mechanisms and factors such as inflammation and oxidative 
stress. Recent studies have shown that renal inflammation is 
essential for the promotion of DN development, and 
inflammation may be a key factor in stimulating known 
biochemical and metabolic disorders in DN. Although 
inflammation has been considered as an important link in the 
occurrence and development of DN, its specific mechanism is 
still inconclusive, and the current methods of diagnosis and 
treatment are still not ideal [2]. 
Long non-coding RNAs (lncRNAs) lack the ability to 
encode proteins and play a key role in many life processes, 
both in the cytoplasm and in the nucleus, with lengths greater 
than 200 nt. Studies have found that lncRNA affects the 
occurrence and development of inflammation in a variety of 
diseases and is associated with DN inflammation [3]. 
However, the exact role of lncRNA in DN inflammation 
remains unclear. In this study, DN mouse kidney tissue and 
normal mouse kidney tissue were sent for detection. The 
second-generation sequencing technology was used to find the 
abnormally expressed lncRNA in the tissue. It was found that 
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the expression of Rpph1 lncRNA was significantly higher in 
the kidney tissue of DN mice. Normal mouse kidney tissue. 
Therefore, further research on Rpph1 was conducted to 
investigate whether Rpph1 is associated with DN 
inflammation and its specific potential role. Then, the 
expression of Rpph1 was detected in high-low glucose 
cultured mesangial cells, and the overexpression plasmid and 
siRNA of Rpph1 were constructed. After transfected into 
mesangial cells, the efficiency was verified by qRT-PCR and 
the inflammation-related factor MCP-1 was detected. The 
expression of TNF-α explores the possible role of Rpph1 in 
DN inflammation and provides a new idea for the treatment of 
DN. 
Materials and methods 
Mouse kidney tissue extraction 
DN model mouse B6.BKS(D)-Leprdb were purchased from 
Pundang Biomedical Research Institute and kept in an SPF lab. 
When the diabetic nephropathy mice and normal mice reached 
15 weeks of age, the mouse kidney tissues were extracted. 
Cell culture and transfection 
The mesangial cells were cultured in low glucose (5 
mmol/L) and DMEM high glucose (25 mmol/L) medium, and 
the fetal bovine serum content was 15%. The cells were named 
L-MC group and H-MC. group. Further, the mesangial cells 
cultured with high glucose in the liposome Lipofectamine 
2000 were named as H-MC mock group, and the mesangial 
cells cultured in high glucose transfected with siRNA negative 
control were named H-MC siNC group. The high-glycemic 
mesangial cells stained with Rpph1 siRNA were named H-MC 
siRpph1 group; in the low glucose cultured mesangial cells, 
only the liposome Lipofectamine 3000 was added to the L-MC 
mock group, which was transfected. The no-load plasmid was 
named L-MC pcDNA3.1 and the Rpph1 overexpression 
plasmid was designated as L-MC Rpph1(+). The cells were 
inoculated with 6-well plates, and the cells were transfected 
when the cells proliferated to 75%-80%. After 5 hours, the 
cells were replaced with medium containing 15% serum. After 
24 hours, the RNA was extracted, and the expression and 
interference efficiency were detected by qRT-PCR. 
LncRNA-Rpph1 encoding protein ability analysis 
Analysis of lncRNA-Rpph1 protein coding using the online 
software ORF Finder (www.ncbi.nlm.nih.gov/orffinder/) and 
CPC2 (Coding Potential Calculator 2) (http://cpc2.cbi.pku. 
edu.cn/) ability. 
Construction of 1.5 pcDNA3.1(+)-Rpph1 eukaryotic express-
ion plasmid 
Rpph1 primers were designed using Primer Premier 5.0 
software, and Pubmed's online alignment primers were 
consistent and specific. The plasmid expression vector was 
pcDNA3.1(+), and Rpph1 was subjected to restriction enzyme 
scanning analysis. The control plasmid cloning site was added 
to the BamHI and EcoRI sites in the upstream and downstream 
primers of Rpph1 to amplify the full-length sequence of 
Rpph1. Its primer sequence is upstream: 5'-GGATCCAGTG-
GGCGGAGGAAGCTCATC-3', downstream: 5'-GATATC-
AGGGCGGGGGAGAGTAGTCTGAA-3'. PCR amplifica-
tion of Rpph1, agarose gel electrophoresis and purification, 
approximately 343 bp, configured with double digestion 
system (BamHI and EcoRI), then incubated at 37 °C for 1 h, 
added T4 ligase 16 °C overnight to connect Rpph1 PCR 
product to true On the nuclear expression vector, E. coli DH5α 
competent cells were transformed according to the procedure, 
150 μL was inoculated onto a plate containing ampicillin (50 
μg/mL), positive monoclonals were selected by plate streaking, 
and cultured overnight, and the results were observed. Add 15 
mL of medium to a 50 mL plastic centrifuge tube, add 
antibiotics, shake at 250 r/min, shaken at 37 °C for 13 to 16 h, 
extract the plasmid according to the kit procedure, measure the 
plasmid concentration, and take the corresponding plasmid for 
double digestion. , agarose gel electrophoresis and sequencing 
identified whether the connection was successful. Pubmed 
online alignment results, if the amplified target fragment and 
the mouse Rpph1 gene sequence homology, indicating that the 
plasmid was successfully constructed. The empty plasmid was 
used as a control group. 
Design and synthesis of Rpph1 small interfering RNA 
Design 3 lines of Rpph1 online by DSIR (http://biodev. 
extra.cea.fr/DSIR/DSIR.html) and siDirect version 2.0 (http:// 
sidirect2.rnai.jp/) with reference to the mouse Rpph1 gene 
sequence. siRNAs sequence. Sequence 1: 5'-CCAGCAGTG-
CGAGTTCAAT-3'; sequence 2: 5'-CGAGTTCAATGGCTG-
AGGT-3'; sequence 3: 5'-GGCCTCATAACCCAATTCA-3'. 
The siRNA sequence was synthesized by Pundong 
Biotechnology Company, and the interference efficiency was 
identified by qRT-PCR. 
qRT-PCR detection of Rpph1 expression 
TRIzol extracts tissue and cellular total RNA, reverse 
transcription according to the PrimerScriptTM instructions, 
and preserves cDNA at -20 °C. The primers for the design of 
Rpph1 and β-actin are then more specific than the ones and 
synthesized by the company. Upstream of Rpph1: 5'-CAGAC-
TGGGCAGGAGAAGCC-3', downstream: 5'-TCACCTCA-
GCCATTGAACTCG-3'; upstream of β-actin: 5'-GCTCAGT-
AACAGTCCGCCTAG-3', downstream: 5'-AGTGTGACGT-
TGACATCCG-3'. Using cDNA as a template, a PCR reaction 
system was used, and the system was 10 μL, and three 
replicate wells were set for each detection index. The PCR 
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procedure was as follows: pre-denaturation at 95 °C for 3 min, 
95 °C for 5 s, 58 °C for 34 s, and 72 °C for 60 s for 40 cycles. 
The relative quantitative data of Rpph1 was analyzed by 2-
ΔΔCt method. 
FISH detection of Rpph1 subcellular localization 
The experimental procedure was carried out according to 
the kit instructions, and the localization of Rpph1 was detected 
in mesangial cells cultured in high glucose and mesangial cells 
cultured in low glucose. The cells were grouped into three 
groups: H-MC, L-MC, Control (only DAPI, cells without 
Rpph1 probe). The cells were seeded in 24-well plates with 
slides and cultured in a cell incubator for 24 h. The 
experimental procedure was as follows: PBS was washed in 
24-well plate 4 times, PBS was aspirated, then 100 μL of 4% 
paraformaldehyde was added to each well, and allowed to 
stand at room temperature for 10 min, 0.5% Triton X-100 was 
added, and 100 μL of 0.5% was added to each well. Triton X-
100, 5 min, increased cell permeability, washed 4 times in PBS 
for 5 min each time, pre-hybridization and hybridization 
solution were preheated in an oven at 37 °C for 30 min before 
use, and 100 μL per well before hybridization. The pre-hybrid 
solution was placed in a 37 ° C incubator for 20 min. The pre-
hybrid solution was gently aspirated with a pipette tip, and the 
lncRNA-Rpph1 FISH probe and the hybridization solution 
were diluted 1:50, and 100 μL of the mixed solution was added 
to each well, protected from light, and hybridized overnight in 
a 37 ° C incubator. The next day, 4×SSC, 2×SSC, and 1×SSC 
were preheated at 50 °C, and the cells were washed three times 
in a high concentration to a low concentration. The tip was 
sucked off the SSC, 10 μL of DAPI working solution was 
added to each well, allowed to stand for 8 min, washed three 
times with PBS, and finally the photograph was taken to obtain 
an image. 
Western blot analysis of TNF-α and MCP-1 expression 
Rpph1 siRNA and overexpression plasmid were transfected 
into mesangial cells cultured in high glucose and low glucose 
respectively. After 2 days, the cells were washed with PBS, 
and the cells were scraped off with cell scraping. After 
centrifugation, the cells were collected, and PMSF and RIPA 
were counted as 1:100 mixed, add appropriate amount of 
lysate, lyse the cells at 4 °C for 40 min, shake the cells 3 times 
during the lysis, centrifuge at 15 000 r/min for 4 min at 4 °C, 
carefully aspirate the supernatant, and perform protein 
quantification test to detect the protein concentration in the 
supernatant. The sample was mixed with 5× protein loading 
buffer at 4:1, and the protein was denatured by boiling at 98 °C 
for 8 min, and placed in a refrigerator at -20 °C. SDS-PAGE 
gel electrophoresis, gelatinization, membrane transfection, 
blocking, rabbit anti-TNF-α primary antibody (1:800 dilution) 
and rabbit anti-MCP-1 primary antibody (1:800 dilution) were 
added, and overnight at 4 °C. The PVDF membrane was 
washed with TBST, and the HRP-labeled goat anti-rabbit IgG 
secondary antibody (1:7 000 dilution) was diluted with TBST, 
added to the PVDF membrane, placed on a shaker at room 
temperature, developed after 2 h, and analyzed by Gray Image 
with Image J software, and GAPDH was the internal reference. 
Statistical analysis 
The experimental data were analyzed by SPSS 19.0 
statistical software. The data of the two groups were compared 
by t test. The data of multiple groups were compared by one-
way ANOVA.  
Results 
Rpph1 is highly expressed in kidney tissues of DN mice and 
mesangial cells cultured in high glucose 
The differentially expressed genes were analyzed by 
second-generation sequencing, and Rpph1 levels were 
significantly up-regulated in kidney tissues of DN mice com- 
Figure 1. qRT-PCR detection of Rpph1 expression in kidney and mesangial cells of DN mice. A: Rpph1 levels were significantly up-
regulated in kidney tissues of DN mice compared to kidney tissues of normal control mice by RNA-sequencing (RNA-seq) (P < 0.05). 
B: Rpph1 level in diabetic nephropathy mice and normal mouse kidneys (*P < 0.01, compared with the Normal group). C: Rpph1 levels 
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Figure 2. CPC2 analysis of the ability of Rpph1 encoding protein. Sequence of Rpph1 got Fickett score 0.36232 with a complete putative ORF 33 AA, 
a pI 5.47760009766, which, in total, classify it as a noncoding sequence with coding probability 0.00938689. Sequence of GAPDH got Fickett score 
0.36845 with a complete putative ORF 303 AA, a pI 9.53704833984, which, in total, classify it as a coding sequence with coding probability 0.99959. 
 
pared to kidney tissues of normal control mice. The expression 
of Rpph1 in DN mouse kidney tissue and normal mouse 
kidney tissue, as well as high glucose cultured mesangial cells 
and low glucose cultured mesangial cells were further 
examined by qRT-PCR. The expression of Rpph1 in kidney 
tissues of DN mice was significantly higher than that in 
normal mice. Similarly, the expression level of Rpph1 in 
mesangial cells in high glucose environment was significantly 
higher than that in low glucose cultured cells (P < 0.05, Fig. 
1). 
Bioinformatics analysis of non-coding Rpph1 
The protein coding ability of Rpph1 was analyzed by CPC2 
and ORF Finder online software. The results showed that 
Rpph1 had no protein coding ability, with GAPDH as control 
(Fig. 2) which suggest that Rpph1 is indeed a lncRNA with no 
protein coding ability. 
Rpph1 is mainly localized in mesangial cell cytoplasm 
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Figure 3. Analysis of Rpph1 expression in 
mesangial cells after transfection of overexpressing 
plasmids and siRNAs. Rpph1 is mainly distributed 
in the cytoplasm of mesangial cells. qRT-PCR result 
shows that Rpph1 is mainly present in the cell 
Cytoplasm of mesangial cells (*P<0.05 and 
**P<0.05, compared with nucleus). 
 
FISH results showed that Rpph1 was distributed in the 
cytoplasm and nucleus of mesangial cells, but mainly in the 
cytoplasm. At the same time, the level of mesangial cells in 
high glucose environment was higher than that in low glucose 
cultured cells (Fig. 3A). In addition, qRT-PCR results 
indicated that Rpph1 was mainly present in the cytoplasmic 
part of mesangial cells (P < 0.05, Figure 3B), consistent with 
the results of the FISH experiment. 
Transfection efficiency of Rpph1 overexpression plasmid and 
screening of Rpph1 siRNAs 
The knockdown efficiency of three Rpph1 siRNAs by qRT-
PCR is shown in Figure 4. The knockdown efficiency of 
siRNA-3 was optimal in mesangial cells cultured in high 
glucose, and the interference efficiency was over 60%. 
Therefore, subsequent experiments will select this siRNA for 
proceeding. At the same time, qRT-PCR confirmed the 
expression of Rpph1 after transfection of Rpph1 
overexpression plasmid in low glucose cultured mesangial 
cells, and its expression level was significantly increased (P < 
0.05). 
Rpph1 promotes the expression of inflammatory factors in 
mesangial cells under high glucose conditions 
The effect of transfection of Rpph1 overexpression plasmid 
and siRNA on the expression of inflammation-related factors 
TNF-α and MCP-1 was detected by Western blot. The results 
showed that the protein expression levels of TNF-α and MCP-
1 were significantly up-regulated after transfection of Rpph1 
overexpression plasmid in low glucose cells (P < 0.05). 
However, after transfection of Rpph1 siRNA in high glucose 
cultured mesangial cells, the protein expression levels of TNF-
α and MCP-1 were significantly decreased (P < 0.05, Figure 
5). It indicates that Rpph1 has a regulatory effect on the 
expression of inflammatory factors in mesangial cells and 
participates in DN inflammation. 
Discussion 
In recent years, more and more studies have found that 
inflammation participates in DN. Many scholars have 
proposed microinflammation theory, which refers to the 
stimulation of some organisms, endotoxin, microorganisms, 
receptors, adipokines, chemokines, etc. Activation of the 
monocyte/macrophage system, a slow and sustained 
microinflammation of increased secretion of inflammation-
related factors, which is thought to be a disease of low-grade 
inflammation and innate immunity, inflammation can cause 
kidney damage, to DN Progress has played a crucial role [5-
6]. The inflammatory response plays an important role in the 
progression of DN, and the abnormal expression of 
inflammatory factors is a typical feature of DN inflammatory 
response. However, due to the numerous complex factors 
involved in the development of DN, the regulation of DN 
inflammatory factors has not been determined. 
lncRNA has become a research hotspot in recent years and 
has participated in many complex regulatory networks. 
lncRNA has many functions and is widely involved in 
biological processes such as histone modification, DNA 
methylation and chromatin remodeling. It can directly interact 
with some RNA molecules and proteins, and regulate the 
expression of target genes at the transcriptional and post-
transcriptional levels [7]. Abnormal expression of lncRNA is  
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Figure 4. qRT-PCR detection of Rpph1 expression in mesangial cells after transfection of overexpressing plasmids and siRNAs. A: Rpph1 
overexpression efficiency was detected in low glucose cultured mesangial cells (*P < 0.05 and #P < 0.05, compared with L-MC Rpph1 (+) group). 
B: High glucose cultured mesangial cells were tested for Rpph1-siRNA knockdown efficiency (**P < 0.05; compared with H-MC mock group; ##P 
< 0.05, compared with H-MC siNC group). 
 
involved in the development of a variety of diseases, including 
cardiovascular disease, neuropathy, cancer and metabolic 
diseases [8]. In addition, the abnormal expression of lncRNA 
plays a crucial role in the development of DN. It has been 
reported that lncRNA is involved in regulating renal response 
to hyperglycemia and promoting DN progression [9]. WANG 
et al [10] reported that lncRNA CYP4B1-PS1-001 was 
significantly down-regulated in vitro and in vivo in early 
diabetic, while overexpression of CYP4B1-PS1-001 inhibited 
mesangial cell proliferation and fibrosis. Not only that, 
lncRNA is also involved in the inflammatory process. 
CARPENTER et al [11] reported that lncRNA-Cox2 was 
identified as a TLR ligand-induced dynamic regulatory gene, 
which in turn promotes and inhibits the expression of 
inflammatory factors; some lncRNAs including THRIL [12], 
lnc13 [13] have been reported to regulate the myeloid system. 
Inflammatory gene expression of cells. It is suggested that 
lncRNA may be involved in DN inflammation, especially in 
the previous study, we found that lncRNA-Gm4419 is highly 
expressed in high glucose cultured mesangial cells and 
regulates DN inflammation through NF-κB signaling pathway 
[14]. Therefore, lncRNA may play an important role in the 
inflammation of diabetic nephropathy, and it is a potential 
novel molecular marker and therapeutic target for DN. 
However, the exact mechanism is still unclear. 
To determine the intrinsic relationship between lncRNA 
and DN, lncRNAs expressing abnormalities in kidney tissues 
of DN mice were identified by RNA-seq, and the relevant 
lncRNAs were analyzed and verified. In this study, qRT-PCR 
was used to verify the expression of lncRNAs in kidney tissues 
of DN mice. Ribonuclease P RNA component H1 (Rpph1) 
was significantly higher in kidney tissues of DN mice than in 
normal control mice. The results also showed that the 
expression of Rpph1 in mesangial cells cultured in high and 
low glucose was consistent with DN and normal kidney tissues. 
All of the above suggest that lncRNA Rpph1 may be a factor 
involved in the occurrence and development of DN. Rpph1 is 
the RNA component of RNase ribonucleoprotein, located on 
mouse chromosome 14 (chr14: 50807447-50807771) and 325 
bp in length. Recent studies have shown that ribonuclease is 
involved in the maturation of lncRNA MALAT1 [15]; Rpph1 
is up-regulated in human gastric cancer tissues [16] and 
neocortex in patients with epilepsy [17]; ZHANG et al [18] 
study proved that Rpph1 knockdown It inhibited the 
proliferation of breast cancer cells and the occurrence of 
tumors, but no reports of Rpph1 and diabetic nephropathy 
have been reported so far. In this experiment, Rpph1 was 
found to have no protein coding ability by coding protein 
proteomic analysis software, and it was confirmed to be non-
coding RNA again. However, the specific role of Rpph1 in DN 
requires further research. 
 
Figure 5. Effect of overexpression and knockdown of Rpph1 on the 
expression of TNF-α and MCP-1 in mesangial cells. 
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In order to explore the specific role of lncRNA-Rpph1 in 
DN, high glucose was used to simulate mesenchymal cells in 
diabetic state [19], and the distribution of Rpph1 in cells was 
detected by fluorescence in situ hybridization and real-time 
fluorescent quantitative PCR. The results suggest that Rpph1 
is distributed in the nucleus and cytoplasm of mesangial cells, 
but mainly distributed in the cytoplasm. The distribution of 
lncRNA in cells is different, and its function is also different. 
If distributed in the cytoplasm, lncRNA mainly participates in 
gene regulation by inhibiting the binding of miRNA to target 
genes by binding to miRNAs, or by binding to specific 
proteins to form a complex; if distributed in the nucleus, it 
plays a role in affecting chromatin remodeling or 
transcriptional regulation [20]. Combined with the results of 
this study, it is suggested that the way Rpph1 works may be 
related to its main distribution in the cytoplasm, that is, 
competitive binding to miRNA or interaction with proteins to 
regulate gene expression. These two modes of action may be 
important mechanisms of Rpph1, which provides us with a 
direction for further research on Rpph1. 
In addition, we successfully constructed Rpph1 overexpre-
ssion plasmid and synthetic Rpph1 siRNA, transfected siRNA 
and overexpression plasmid in mesangial cells cultured in high 
glucose and low glucose, respectively, and detected the 
overexpression and knockdown efficiency of Rpph1 by qRT-
PCR. Overexpression and silencing efficiency are good, 
which provides a good basis for the later experimental study 
of the function of Rpph1 in mesangial cells. 
To investigate the role of Rpph1 in DN inflammation, we 
turned our attention to two important inflammation-related 
factors, TNF-α and MCP-1. The study found that TNF-α is 
mainly produced by macrophages, T cells, and monocytes, 
and can also be found in kidney-derived cells such as dendritic 
cells, mesangial cells, endothelial cells, and renal tubular cells. 
Secretion of synthetic pleiotropic inflammation-related factors 
[21]; TNF-α is involved in the recruitment of monocyte-
macrophages and induces local inflammation by initiating a 
series of cytokines and increasing vascular permeability, and 
TNF-α on kidney cells Cytotoxicity, which can directly induce 
kidney injury, is an important factor causing inflammation of 
diabetic nephropathy [22]; CHOW et al [23] proved the 
pathogenic role of MCP-1 in diabetic nephropathy, knocking 
out MCP in diabetic model mice After -1, its kidney damage 
was alleviated. In diabetic nephropathy, MCP-1 is up-
regulated, MCP-1 can promote the migration and activation of 
monocyte-macrophage, and regulate the expression of other 
inflammatory factors and adhesion factors, thereby promoting 
the development of inflammation of diabetic nephropathy [24-
26]. In this study, Rpph1 was overexpressed in low glucose 
cultured mesangial cells and Rpph1 was silenced in high 
glucose cultured mesangial cells. Western blot was used to 
detect the expression of TNF-α and MCP-1. The results 
showed that the expression levels of TNF-α and MCP-1 were 
significantly increased after overexpression of Rpph1. 
Conversely, the expression of TNF-α and MCP-1 was 
significantly decreased after down-regulation of Rpph1 (P < 
0.01). These results suggest that Rpph1 may participate in the 
occurrence and development of DN inflammation by 
promoting the expression of inflammatory factors TNF-α and 
MCP-1. 
In summary, this study found that the abnormally high 
expression of lncRNA Rpph1 in DN mouse kidney tissue and 
high glucose cultured mesangial cells, and high and low 
expression of Rpph1 can regulate mesangial cell inflammatory 
factors TNF-α and MCP-1 Expression, thus participating in 
the occurrence and development of DN inflammation. 
Therefore, the role of Rpph1 in DN can provide a new 
direction for the prevention and treatment of DN. However, 
the effect of lncRNA on DN is an extremely complicated 
process. The specific mechanism of Rpph1 in DN 
inflammation needs further study. 
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